TSE:GUD - Knight Therapeutics News Headlines

C$7.55
+0.05 (+0.67 %)
(As of 07/21/2019 11:34 AM ET)
Today's Range
C$7.47
Now: C$7.55
C$7.58
50-Day Range
C$7.41
MA: C$7.57
C$7.77
52-Week Range
C$7.10
Now: C$7.55
C$8.76
Volume280,900 shs
Average Volume340,490 shs
Market CapitalizationC$1.08 billion
P/E Ratio48.40
Dividend YieldN/A
BetaN/A

Headlines

Knight Therapeutics (TSE GUD) News Headlines

Source:
DateHeadline
Raymond James Reiterates "C$10.25" Price Target for Knight Therapeutics (TSE:GUD)Raymond James Reiterates "C$10.25" Price Target for Knight Therapeutics (TSE:GUD)
www.americanbankingnews.com - July 18 at 2:27 PM
Medison Biotech Considers Requisition of Special Meeting of Shareholders of Knight Therapeutics Inc.Medison Biotech Considers Requisition of Special Meeting of Shareholders of Knight Therapeutics Inc.
finance.yahoo.com - July 18 at 12:05 PM
Insider Buying: Knight Therapeutics Inc (TSE:GUD) Director Purchases 20,000 Shares of StockInsider Buying: Knight Therapeutics Inc (TSE:GUD) Director Purchases 20,000 Shares of Stock
www.americanbankingnews.com - July 15 at 11:38 AM
Medison Biotech: Jonathan Goodman Takes Advantage of His Own Failure to Create Value, Enriching Himself at the Expense of the Shareholders of Knight TherapeuticsMedison Biotech: Jonathan Goodman Takes Advantage of His Own Failure to Create Value, Enriching Himself at the Expense of the Shareholders of Knight Therapeutics
finance.yahoo.com - July 9 at 11:34 AM
Knight Announces Filing of New Drug Submission for Ibsrela™ in CanadaKnight Announces Filing of New Drug Submission for Ibsrela™ in Canada
finance.yahoo.com - June 26 at 11:31 AM
Knight has less skin in Medimetriks through full loan repaymentKnight has less skin in Medimetriks through full loan repayment
finance.yahoo.com - June 18 at 6:19 PM
Is Knight Therapeutics Inc.'s (TSE:GUD) CEO Being Overpaid?Is Knight Therapeutics Inc.'s (TSE:GUD) CEO Being Overpaid?
finance.yahoo.com - June 7 at 7:52 PM
Knight to Present at the Jefferies 2019 Global Healthcare Conference in New York CityKnight to Present at the Jefferies 2019 Global Healthcare Conference in New York City
finance.yahoo.com - May 29 at 11:16 AM
Canada’s Most Undervalued Pharmaceutical Stock Is a Buy!Canada’s Most Undervalued Pharmaceutical Stock Is a Buy!
www.msn.com - May 24 at 4:05 PM
Knight to Present at the National Bank Financial Markets 9th Annual Quebec Conference in TorontoKnight to Present at the National Bank Financial Markets 9th Annual Quebec Conference in Toronto
finance.yahoo.com - May 23 at 4:08 PM
Knight to Present at the 2019 RBC Capital Markets Global Healthcare Conference in New York CityKnight to Present at the 2019 RBC Capital Markets Global Healthcare Conference in New York City
finance.yahoo.com - May 15 at 9:07 PM
Edited Transcript of GUD.TO earnings conference call or presentation 9-May-19 12:30pm GMTEdited Transcript of GUD.TO earnings conference call or presentation 9-May-19 12:30pm GMT
finance.yahoo.com - May 10 at 4:06 PM
Notice of Knight Therapeutics First Quarter 2019 Results Conference CallNotice of Knight Therapeutics' First Quarter 2019 Results Conference Call
finance.yahoo.com - May 2 at 11:49 AM
What Type Of Shareholder Owns Knight Therapeutics Inc.'s (TSE:GUD)?What Type Of Shareholder Owns Knight Therapeutics Inc.'s (TSE:GUD)?
finance.yahoo.com - May 1 at 4:01 PM
Medison Urges Knight Shareholders to Demand Answers to Critical Questions from Jonathan Goodman at the Bloom Burton & Co. Healthcare Investor ConferenceMedison Urges Knight Shareholders to Demand Answers to Critical Questions from Jonathan Goodman at the Bloom Burton & Co. Healthcare Investor Conference
finance.yahoo.com - April 30 at 11:25 AM
Medison Urges Fellow Shareholders to Bring Positive Change to Knight Therapeutics by Voting for All Six of Medisons Highly Qualified Nominees at Upcoming Annual MeetingMedison Urges Fellow Shareholders to Bring Positive Change to Knight Therapeutics by Voting for All Six of Medison's Highly Qualified Nominees at Upcoming Annual Meeting
finance.yahoo.com - April 29 at 11:25 AM
Knight to Present at the 2019 Bloom Burton & Co. Healthcare Investor Conference in TorontoKnight to Present at the 2019 Bloom Burton & Co. Healthcare Investor Conference in Toronto
finance.yahoo.com - April 26 at 11:29 AM
Leading Independent Proxy Advisor, Key Shareholders, and More Analysts Back Jonathan Goodman’s Knight, Recommend Meir ...Leading Independent Proxy Advisor, Key Shareholders, and More Analysts Back Jonathan Goodman’s Knight, Recommend Meir ...
www.globenewswire.com - April 25 at 4:02 PM
Leading Independent Proxy Advisor, Key Shareholders, and More Analysts Back Jonathan Goodman’s Knight, Recommend Meir Jakobsohn Not be Re-elected to the BoardLeading Independent Proxy Advisor, Key Shareholders, and More Analysts Back Jonathan Goodman’s Knight, Recommend Meir Jakobsohn Not be Re-elected to the Board
finance.yahoo.com - April 25 at 4:02 PM
Medison Issues Presentation to Knight ShareholdersMedison Issues Presentation to Knight Shareholders
finance.yahoo.com - April 18 at 12:17 PM
Leading Canadian Corporate Governance Expert Confirms Acute Board Conflicts and Governance Deficiencies at Knight TherapeuticsLeading Canadian Corporate Governance Expert Confirms Acute Board Conflicts and Governance Deficiencies at Knight Therapeutics
finance.yahoo.com - April 17 at 10:13 AM
Knight Therapeutics: Use of PROBUPHINE(TM) for Opioid Disorder Gains Momentum Across Canada; Subdermal Implant Now in Use from Coast to CoastKnight Therapeutics: Use of PROBUPHINE(TM) for Opioid Disorder Gains Momentum Across Canada; Subdermal Implant Now in Use from Coast to Coast
www.marketwatch.com - April 12 at 6:40 PM
Knight Therapeutics: Use of PROBUPHINE™ for Opioid Disorder Gains Momentum Across Canada; Subdermal Implant Now in Use from Coast to CoastKnight Therapeutics: Use of PROBUPHINE™ for Opioid Disorder Gains Momentum Across Canada; Subdermal Implant Now in Use from Coast to Coast
finance.yahoo.com - April 12 at 6:40 PM
Knight Receives Unanimous Support from Independent Analysts for Director Nominees, Current StrategyKnight Receives Unanimous Support from Independent Analysts for Director Nominees, Current Strategy
finance.yahoo.com - April 10 at 9:08 PM
Medison Disappointed that Knight Therapeutics has Resorted to Blatant Misrepresentations to Avoid ScrutinyMedison Disappointed that Knight Therapeutics has Resorted to Blatant Misrepresentations to Avoid Scrutiny
finance.yahoo.com - April 10 at 4:08 PM
Knight Therapeutics Continues to Demonstrate Winning Strategy; Files Investor Presentation, Launches MicrositeKnight Therapeutics Continues to Demonstrate Winning Strategy; Files Investor Presentation, Launches Microsite
finance.yahoo.com - April 8 at 10:29 AM
Medison Files Proxy Circular, Offers Knight Therapeutics Shareholders Truly Independent, Unconflicted Directors and Comprehensive Business Plan to Fix a Failing KnightMedison Files Proxy Circular, Offers Knight Therapeutics Shareholders Truly Independent, Unconflicted Directors and Comprehensive Business Plan to Fix a Failing Knight
finance.yahoo.com - April 8 at 10:29 AM
Knight Files Management Information Circular, Warns Shareholders of Activist Jakobsohn’s Self-Interested AgendaKnight Files Management Information Circular, Warns Shareholders of Activist Jakobsohn’s Self-Interested Agenda
finance.yahoo.com - April 4 at 12:09 PM
Edited Transcript of GUD.TO earnings conference call or presentation 14-Mar-19 12:30pm GMTEdited Transcript of GUD.TO earnings conference call or presentation 14-Mar-19 12:30pm GMT
finance.yahoo.com - March 16 at 12:10 PM
Notice of Knight Therapeutics 2018 Fourth Quarter and Year End Results Conference CallNotice of Knight Therapeutics' 2018 Fourth Quarter and Year End Results Conference Call
finance.yahoo.com - March 8 at 12:15 PM
Knight Therapeutics Comments on Flawed Accusations by Disgruntled Board Member; Remains Committed to Executing Strategy that is WorkingKnight Therapeutics Comments on Flawed Accusations by Disgruntled Board Member; Remains Committed to Executing Strategy that is Working
finance.yahoo.com - March 1 at 12:12 PM
Knight Therapeutics Investor Presses for CEO to Cut Family TiesKnight Therapeutics Investor Presses for CEO to Cut Family Ties
finance.yahoo.com - February 28 at 3:59 PM
Are Knight Therapeutics Inc.’s (TSE:GUD) Interest Costs Too High?Are Knight Therapeutics Inc.’s (TSE:GUD) Interest Costs Too High?
finance.yahoo.com - February 21 at 1:23 PM
Based On Its ROE, Is Knight Therapeutics Inc. (TSE:GUD) A High Quality Stock?Based On Its ROE, Is Knight Therapeutics Inc. (TSE:GUD) A High Quality Stock?
finance.yahoo.com - January 22 at 11:06 AM
A brain-damaged CEO has a hot new venture—and investors are piling inA brain-damaged CEO has a hot new venture—and investors are piling in
www.theglobeandmail.com - January 21 at 8:46 AM
Did Knight Therapeutics Inc. (TSE:GUD) Insiders Sell Shares?Did Knight Therapeutics Inc. (TSE:GUD) Insiders Sell Shares?
finance.yahoo.com - December 20 at 11:01 AM
Edited Transcript of GUD.TO earnings conference call or presentation 8-Nov-18 1:30pm GMTEdited Transcript of GUD.TO earnings conference call or presentation 8-Nov-18 1:30pm GMT
finance.yahoo.com - November 9 at 11:07 AM
Do Institutions Own Knight Therapeutics Inc (TSE:GUD) Shares?Do Institutions Own Knight Therapeutics Inc (TSE:GUD) Shares?
finance.yahoo.com - November 8 at 3:33 PM
Todays Research Reports on Knight Therapeutics, Covalon Technologies, Titan Medical and NeovascToday's Research Reports on Knight Therapeutics, Covalon Technologies, Titan Medical and Neovasc
finance.yahoo.com - October 29 at 9:15 AM
A Look At Knight Therapeutics Inc (TSE:GUD) And The Healthcare SectorA Look At Knight Therapeutics Inc (TSE:GUD) And The Healthcare Sector
finance.yahoo.com - October 4 at 3:24 PM
Jaguar Health's stock triples after licensing deal, has been halted 13 times for volatilityJaguar Health's stock triples after licensing deal, has been halted 13 times for volatility
finance.yahoo.com - September 25 at 3:24 PM
Knight to Present at the Cantor Fitzgerald Global Healthcare Conference in New York CityKnight to Present at the Cantor Fitzgerald Global Healthcare Conference in New York City
finance.yahoo.com - September 25 at 9:51 AM
TTNP: First Internal Sales of ProbuphineTTNP: First Internal Sales of Probuphine
finance.yahoo.com - September 7 at 3:23 PM
Knight to Participate at the Morgan Stanley Global Healthcare Conference in New York CityKnight to Participate at the Morgan Stanley Global Healthcare Conference in New York City
finance.yahoo.com - September 6 at 9:40 AM
What Investors Should Know About Knight Therapeutics Inc’s (TSE:GUD) Financial StrengthWhat Investors Should Know About Knight Therapeutics Inc’s (TSE:GUD) Financial Strength
finance.yahoo.com - September 4 at 3:24 PM
Knight Disposes of a Toddler-Sized Amount of Pediapharm Inc.Knight Disposes of a Toddler-Sized Amount of Pediapharm Inc.
finance.yahoo.com - September 1 at 9:34 AM
Todays Research Reports on Knight Therapeutics, Covalon Technologies, Cotinga Pharmaceuticals and Baylin TechnologiesToday's Research Reports on Knight Therapeutics, Covalon Technologies, Cotinga Pharmaceuticals and Baylin Technologies
finance.yahoo.com - August 27 at 9:48 AM
Edited Transcript of GUD.TO earnings conference call or presentation 9-Aug-18 12:30pm GMTEdited Transcript of GUD.TO earnings conference call or presentation 9-Aug-18 12:30pm GMT
finance.yahoo.com - August 10 at 8:58 AM
Knight Therapeutics Reports Second Quarter 2018 ResultsKnight Therapeutics Reports Second Quarter 2018 Results
finance.yahoo.com - August 9 at 9:09 AM
5 Reasons Why This Pharma Stock Is Poised for Takeoff5 Reasons Why This Pharma Stock Is Poised for Takeoff
www.fool.ca - August 4 at 3:22 PM
This page was last updated on 7/21/2019 by MarketBeat.com Staff

Featured Article: What is a Swap?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel